about
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient po...
Read More
2.01
0.05
(2.55%)
640.1K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Genprex Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..